Thinking Forward: A Revolutionary Model That Delivers Value and Market Opportunity for Personalized MedicinesIDC
July 11, 2008
5 Pages - SKU: IDC1838832
More In Vitro Diagnostics reports by IDC
Eclipsys: An HIT First Responder with H1N1 Influenza Toolkit by IDC
This Health Industry Insights Perspective assesses Eclipsys' release of an influenza A H1N1 outcomes toolkit. On May 4, 2009, just days after the April 22, ...
Intel Receives FDA Clearance for New Remote Patient Monitoring Device by IDC
This Health Industry Insights NewsFlash examines Intel Corp.'s announcement made on July 10, that it had received approval of its application for a 510(k) ...
Payers on the Future of Personalized Medicine, Part 1: Getting Ready for Change by IDC
This Health Industry Insights report identifies and discusses initial insights obtained from Health Industry Insights' 2007 Personalized Medicine Payer Survey regarding the adoption of ...
Theranostics: Life at the Beginning of the Economics Bell Curve by IDCSee all reports like this >>
This Health Industry Insights Perspective provides insights on the anticipated progress and adoption of the area of theranostics. Theranostics is an emerging solution in ...
We can help you find what you need. Call us or write us:
Need help in your search?
In Vitro Diagnostics Reports
- The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
- In Vitro Diagnostics Markets in China
- Cancer Diagnostic Testing World Markets
- Drugs of Abuse: An Analysis of the Point-of-Care Testing Market: US, Germany, Spain, Physician Offices, Emergency Rooms, Ambulatory Care Centers
- 2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers